A new study from Penn Nursing suggests that a promising weight-loss drug, tirzepatide, could cause fewer unpleasant side ...
It's being described as the best weight-loss jab yet -with results that outstrip Wegovy or Mounjaro. But anyone hoping to try ...
In patients with T2D, the risks for gastroesophageal reflux disease and related complications are greater with GLP-1 RA ...
In a further comparison using DPP-4i/SU as the reference, the GLP-1 RA/SGLT2i combination therapy had the greatest effect in ...
Flying with Ozempic, Wegovy, or Mounjaro? Experts explain what happens inside your body when a dose is delayed and why one ...
Glycemic, weight, and cardiometabolic outcomes were improved for children and adolescents treated with GLP-1 RAs.
Placebo-subtracted mean weight loss up to 14.1%after 28 weeks with no plateauPotential for best-in-class tolerability with minimal diarrhea ...
News-Medical.Net on MSN
Cannabidiol shows promise for obesity and metabolic syndrome
Cannabidiol (CBD) shows promise in regulating appetite, glucose and lipid metabolism, and inflammation in preclinical models ...
India embraces GLP-1 medications as a major advance in diabetes and obesity care. At AajTak Health Summit, endocrinologist Dr. Ambrish Mithal and Vikrant Shrotriya, Vice President MD, Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback